钙蛋白酶1(CAPN1)重组蛋白

YB964Ra021
Calpain 1, Large Subunit (CAPN1)
Organism Species: Homo sapiens (Human)
Instruction manual
FOR IN VITRO USE AND RESEARCH USE ONLY
NOT FOR USE IN CLINICAL DIAGNOSTIC PROCEDURES
9th Edition (Revised in Jul, 2013)
钙蛋白酶1(CAPN1)重组蛋白[ PROPERTIES ]
Residues: Pro75~Arg343 (Accession # P07384),
with N-terminal His-Tag.
Host: E. coli
Subcellular Location: Cytoplasm. Cell
membrane. Purity: >95%
Endotoxin Level: <1.0EU per 1μg
(determined by the LAL method).
Formulation: Supplied as lyophilized form in PBS,
pH7.4, containing 5% sucrose, 0.01% sarcosyl.
Predicted isoelectric point: 5.5
钙蛋白酶1(CAPN1)重组蛋白Predicted Molecular Mass: 31.8kDa
Applications: SDS-PAGE; WB; ELISA; IP.
(May be suitable for use in other assays to be determined by the end user.)
[ USAGE ]
Reconstitute in sterile PBS, pH7.2-pH7.4.
[ STORAGE AND STABILITY ]
Storage: Avoid repeated freeze/thaw cycles.
Store at 2-8oC for one month.
Aliquot and store at -80oC for 12 months.
Stability Test: The thermal stability is described by the loss rate of the target
protein. The loss rate was determined by accelerated thermal degradation test,
that is, incubate the protein at 37oC for 48h, and no obvious degradation and
precipitation were observed. (Referring from China Biological Products Standard,
which was calculated by the Arrhenius equation.) The loss of this protein is less
than 5% within the expiration date under appropriate storage condition.
钙蛋白酶1(CAPN1)重组蛋白[ SEQUENCES ]
The target protein is fused with N-terminal His-Tag, its sequence is listed below.
MGHHHHHHSGSEF-PNSSKT YGIKWKRPTE LLSNPQFIVD GATRTDICQG ALGDCWLLAA
IASLTLNDTL LHRVVPHGQS FQNGYAGIFH FQLWQFGEWV DVVVDDLLPI KDGKLVFVHS
AEGNEFWSAL LEKAYAKVNG SYEALSGGST SEGFEDFTGG VTEWYELRKA PSDLYQIILK
ALERGSLLGC SIDISSVLDM EAITFKKLVK GHAYSVTGAK QVNYRGQVVS LIRMRNPWGE
VEWTGAWSDS SSEWNNVDPY ERDQLRVKME DGEFWMSFRD FMR
[ REFERENCES ]
1. Nguyen H.T., et al. (2012) Biochem. Biophys. Res. Commun. 420:530-535. 2. Liang J.L., et al. (2012) Arch. Pharm. Res. 35:447-454. 3. Hou J., et al. (2012) FEBS Lett. 586:892-896. 4. Salehin D., et al. (2011) Eur. J. Gynaecol. Oncol. 32:628-635.